Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-27

Clinical Trial Update: UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating Umbilical Cord Mesenchymal Stem Cells (UCMSCs) combined with standard therapy for newly diagnosed Type 1 diabetes mellitus is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Mesenchymal Stem Cells (UCMSCs) (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Newly Diagnosed Type 1 Diabetes Mellitus | NA | Status: RECRUITING